Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

14.80
Delayed Data
As of May 25
 +0.26 / +1.79%
Today’s Change
9.16
Today|||52-Week Range
17.55
-12.17%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close14.54
Today’s open14.63
Day’s range14.45 - 14.85
Volume1,018,795
Average volume (3 months)1,502,239
Market cap$2.0B
Dividend yield--
Data as of 05/25/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-52.93%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book305.98

Competitors

 Today’s
change
Today’s
% change
DBVTDBV Technologies SA+0.18+0.56%
INCRINC Research Holding...-0.07-0.16%
ARIAARIAD Pharmaceutical...+0.18+2.26%
EXELExelixis Inc+0.08+1.30%
Data as of 05/25/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs